Platelet-derived growth factor-BB increases expression of connexin43 in an extracellular-regulated protein kinase-dependent manner in bladder smooth muscle cells

International Journal of Urology

Volumn 20, Issue 1, 2013, Pages 123-130

  Shen, Wenhao ^a   Li, Longkun ^a   Song, Bo ^a   Li, Weibing ^a   Zhou, Zhansong ^a   Guo, Ruiwei ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

Connexin 43; Detrusor overactivity; Extracellular regulated protein kinases; Platelet derived growth factor BB

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CONNEXIN 43; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; MALE; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; UPREGULATION;

ANIMALS; CELLS, CULTURED; CONNEXIN 43; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE KNOCKDOWN TECHNIQUES; MALE; MAP KINASE SIGNALING SYSTEM; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; UP-REGULATION; URINARY BLADDER, OVERACTIVE;

EID: 84871932301     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03192.x     Document Type: Article

References (28)

1. Wang HZ, Brink PR, Christ GJ. Gap junction channel activity in short-term cultured human detrusor myocyte cell pairs: gating and unitary conductances. Am. J. Physiol. Cell Physiol. 2006; 291: C1366-1376.
2. Christ GJ, Day NS, Day M etal. Increased connexin43-mediated intercellular communication in a rat model of bladder overactivity in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003; 284: R1241-1248.
3. Haferkamp A, Mundhenk J, Bastian PJ etal. Increased expression of connexin 43 in the overactive neurogenic detrusor. Eur. Urol. 2004; 46: 799-805.
4. Ikeda Y, Fry C, Hayashi F, Stolz D, Griffiths D, Kanai A. Role of gap junctions in spontaneous activity of the rat bladder. Am. J. Physiol. Renal Physiol. 2007; 293: F1018-1025.
5. Li L, Jiang C, Hao P, Li W, Song C, Song B. Changes of gap junctional cell-cell communication in overactive detrusor in rats. Am. J. Physiol. Cell Physiol. 2007; 293: C1627-1635.
6. Sui GP, Rothery S, Dupont E, Fry CH, Severs NJ. Gap junctions and connexin expression in human suburothelial interstitial cells. BJU Int. 2002; 90: 118-129.
7. Hossain MZ, Ao P, Boynton AL. Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liver epithelial cells expressing platelet-derived growth factor receptor. J. Cell. Physiol. 1998; 174: 66-77.
8. Hossain MZ, Jagdale AB, Ao P, Kazlauskas A, Boynton AL. Disruption of gap junctional communication by the platelet-derived growth factor is mediated via multiple signaling pathways. J. Biol. Chem. 1999; 274: 10489-10496.
9. Yao J, Suwa M, Li B, Kawamura K, Morioka T, Oite T. ATP-dependent mechanism for coordination of intercellular Ca2+ signaling and renin secretion in rat juxtaglomerular cells. Circ. Res. 2003; 93: 338-345.
10. Yao J, Morioka T, Oite T. PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3-kinase in mesangial cells. Kidney Int. 2000; 57: 1915-1926.
11. Hossain MZ, Ao P, Boynton AL. Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. J. Cell. Physiol. 1998; 176: 332-341.
12. Levitzki A. PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine Growth Factor Rev. 2004; 15: 229-235.
13. Akbal C, Lee SD, Jung C, Rink R, Kaefer M. Upregulation of both PDGF-BB and PDGF-BB receptor in human bladder fibroblasts in response to physiologic hydrostatic pressure. J. Pediatr. Urol. 2006; 2: 402-408.
14. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996; 84: 381-388.
15. Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004; 15: 197-204.
16. Vantler M, Caglayan E, Zimmermann WH, Baumer AT, Rosenkranz S. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important. J. Biol. Chem. 2005; 280: 14168-14176.
17. Vantler M, Huntgeburth M, Caglayan E, Ten Freyhaus H, Schnabel P, Rosenkranz S. PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases. FEBS Lett. 2006; 580: 6769-6776.
18. Trosko JE, Madhukar BV, Chang CC. Endogenous and exogenous modulation of gap junctional intercellular communication: toxicological and pharmacological implications. Life Sci. 1993; 53: 1-19.
19. Haefliger JA, Tissieres P, Tawadros T etal. Connexins 43 and 26 are differentially increased after rat bladder outlet obstruction. Exp. Cell Res. 2002; 274: 216-225.
20. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 2003; 83: 1359-1400.
21. Neuhaus J, Pfeiffer F, Wolburg H, Horn LC, Dorschner W. Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int. 2005; 96: 670-676.
22. Miyazato M, Sugaya K, Nishijima S etal. Changes of bladder activity and connexin 43-derived gap junctions after partial bladder-outlet obstruction in rats. Int. Urol. Nephrol. 2009; 41: 815-821.
23. Graves LM, Bornfeldt KE, Sidhu JS etal. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J. Biol. Chem. 1996; 271: 505-511.
24. Mallat A, Gallois C, Tao J etal. Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. J. Biol. Chem. 1998; 273: 27300-27305.
25. Yao J, Kitamura M, Zhu Y etal. Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am. J. Physiol. Renal Physiol. 2006; 290: F1083-1093.
26. Warn-Cramer BJ, Lampe PD, Kurata WE etal. Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. J. Biol. Chem. 1996; 271: 3779-3786.
27. Maniscalco M, Singh-Franco D, Wolowich WR, Torres-Colon R. Solifenacin succinate for the treatment of symptoms of overactive bladder. Clin. Ther. 2006; 28: 1247-1272.
28. Levitzki A. PDGF receptor kinase inhibitors for the treatment of restenosis. Cardiovasc. Res. 2005; 65: 581-586.